Enochian Biosciences: A 21.6% Better Bargain Than When Sindlev Bought
May 23, 2022 at 10:19 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on May 18, Enochian Biosciences Inc's Director, Rene Sindlev, invested $2,027,944.00 into 253,493 shares of ENOB, for a cost per share of $8.00..